Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09PJK
|
||||
Former ID |
DIB000396
|
||||
Drug Name |
ACK-1 inhibitors
|
||||
Synonyms |
ACK-1 inhibitors (cancer); ACK-1 inhibitors (cancer), Amgen; Activated Cdc42Hs-associated tyrosine kinase-1 inhibitors (cancer), Amgen
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [552118] | ||
Company |
Amgen Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CCCN1CCOc1c(cc(cc1)Nc1ncc2c(n1)n(nc2Nc1c(cccc1C)C)CCC<br />(C)(C)OC)F
|
||||
Target and Pathway | |||||
Target(s) | Activated CDC42 kinase 1 | Target Info | Inhibitor | [543581] | |
NetPath Pathway | TSH Signaling Pathway | ||||
Pathway Interaction Database | CDC42 signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.